132 related articles for article (PubMed ID: 7529431)
21. Imaging prostate cancer.
Yu KK; Hricak H
Radiol Clin North Am; 2000 Jan; 38(1):59-85, viii. PubMed ID: 10664667
[TBL] [Abstract][Full Text] [Related]
22. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
Singh AK; Krieger A; Lattouf JB; Guion P; Grubb RL; Albert PS; Metzger G; Ullman K; Smith S; Fichtinger G; Ocak I; Choyke P; Ménard C; Coleman J
BJU Int; 2008 Jan; 101(2):181-5. PubMed ID: 17922874
[TBL] [Abstract][Full Text] [Related]
23. [Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods].
Böni RA; Hutter BE; Trinkler F; Jochum W; Pestalozzi D; Krestin GP
Rofo; 1996 Aug; 165(2):152-8. PubMed ID: 8924668
[TBL] [Abstract][Full Text] [Related]
24. [Prostatic cancer: role of echography in the diagnosis, evaluation and surveillance].
Fornage B
Bull Cancer; 1985; 72(5):442-51. PubMed ID: 2416372
[TBL] [Abstract][Full Text] [Related]
25. [Endorectal magnetic resonance imaging of the prostate and bladder].
Sugimura Y; Hayashi N; Yamashita A; Kinbara H; Arima K; Tochigi H; Kawamura J
Hinyokika Kiyo; 1994 Jan; 40(1):31-6. PubMed ID: 7509118
[TBL] [Abstract][Full Text] [Related]
26. State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.
Heijmink SW; Fütterer JJ; Strum SS; Oyen WJ; Frauscher F; Witjes JA; Barentsz JO
Acta Oncol; 2011 Jun; 50 Suppl 1():25-38. PubMed ID: 21604938
[TBL] [Abstract][Full Text] [Related]
27. Imaging clinically localized prostate cancer.
Purohit RS; Shinohara K; Meng MV; Carroll PR
Urol Clin North Am; 2003 May; 30(2):279-93. PubMed ID: 12735504
[TBL] [Abstract][Full Text] [Related]
28. [The value of ultrasound-guided multiple systematic biopsies in the early diagnosis of cancer of the prostate].
Billebaud T; Sibert A; Dauge MC; Boccon-Gibod L; Baron JC; Villers A; Delmas V; Boccon-Gibod L
Ann Urol (Paris); 1990; 24(6):524-9. PubMed ID: 1702962
[TBL] [Abstract][Full Text] [Related]
29. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer imaging: what the urologist wants to know.
Talab SS; Preston MA; Elmi A; Tabatabaei S
Radiol Clin North Am; 2012 Nov; 50(6):1015-41. PubMed ID: 23122036
[TBL] [Abstract][Full Text] [Related]
31. [Magnetic resonance tomography in prostatic carcinoma and benign prostatic diseases with an endorectal and a new combined endorectal body phased-array coil].
Engelhard K; Hollenbach HP; Ott G; Hausmann J; Risse W; Riedl C
Rontgenpraxis; 1999; 52(7):214-23. PubMed ID: 10605323
[No Abstract] [Full Text] [Related]
32. [Evolution of modern imaging and development of targeted prostatic biopsies for the diagnosis of prostate cancer].
Audenet F; Rouprêt M; Mozer P
Prog Urol; 2011 May; 21 Suppl 3():S93-5. PubMed ID: 21616447
[TBL] [Abstract][Full Text] [Related]
33. Role of MRI in prostate cancer detection.
Shukla-Dave A; Hricak H
NMR Biomed; 2014 Jan; 27(1):16-24. PubMed ID: 23495081
[TBL] [Abstract][Full Text] [Related]
34. [Imaging of prostate cancer by diagnostic radiology and nuclear medicine].
Weidner A; Michaely HJ; Pelzer A; Michel MS; Wenz F; Schoenberg SO; Dinter DJ
Aktuelle Urol; 2010 Jan; 41(1):35-42. PubMed ID: 20101785
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
36. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
37. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
38. [Endosonography of the prostate].
Hammerer P
Urologe A; 1991 Nov; 30(6):370-7. PubMed ID: 1722920
[TBL] [Abstract][Full Text] [Related]
39. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer and the role of color Doppler US.
Kelly IM; Lees WR; Rickards D
Radiology; 1993 Oct; 189(1):153-6. PubMed ID: 7690489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
